1-3 of 3
Robrecht De Bock
Close
Sort by
Journal Articles

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

Clinical Trials & Observations
Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachée, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2009) 113 (22): 5401–5411.
https://doi.org/10.1182/blood-2008-12-196543
Published: 2009
Journal Articles

Patient Nonadherence and Treatment Response to Imatinib in Patients with Chronic Myeloid Leukemia: Results from the ADAGIO Study

Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachee, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, Laurie Letvak, Ivo Abraham
Journal: Blood
Blood (2008) 112 (11): 2379.
https://doi.org/10.1182/blood.V112.11.2379.2379
Published: 2008
Journal Articles

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Boris Labar, MD, PhD, Stefan Suciu, PhD, Petra Muus, MD, Roelof Willemze, MD, PhD, Jean-Pierre Marie, MD, Georges Fillet, MD, Zwi Berneman, MD, Branimir Jaksic, MDPhD, Walter Feremans, MD, Dominique Bron, MD, Henry Sinnige, MD, Martin Mistrik, MD, G. Vreugdenhil, MD, Robrecht De Bock, MD, Damir Nemet, MD, Caroline Gilotay, Theo de Witte, MDPhD, Sergio Amadori, MD
Journal: Blood
Blood (2005) 106 (11): 1834.
https://doi.org/10.1182/blood.V106.11.1834.1834
Published: 2005